Metabolism and mechanism of action of 5-fluorouracil.
暂无分享,去创建一个
Y. Cheng | W. Parker | Y C Cheng | W B Parker | Yung‐chi Cheng | Y. Cheng | Y. Cheng
[1] R. Diasio,et al. Evidence from rat hepatocytes of an unrecognized pathway of 5-fluorouracil metabolism with the formation of a glucuronide derivative. , 1985, Cancer research.
[2] D. Kufe,et al. Biologic effect of 5-fluoro-2'-deoxyuridine incorporation in L1210 deoxyribonucleic acid. , 1983, Biochemical pharmacology.
[3] S. Spiegelman,et al. Improving the anti-tumor activity of 5-fluorouracil by increasing its incorporation into RNA via metabolic modulation. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[4] L. Grossman,et al. Enzymes involved in the repair of damaged DNA. , 1981, Archives of biochemistry and biophysics.
[5] U. Lönn,et al. DNA lesions in human neoplastic cells and cytotoxicity of 5-fluoropyrimidines. , 1986, Cancer research.
[6] R. Diasio,et al. 5-Fluorouracil incorporation into DNA of CF-1 mouse bone marrow cells as a possible mechanism of toxicity. , 1984, Cancer research.
[7] P. Danenberg,et al. Evidence that intracellular synthesis of 5-fluorouridine-5'-phosphate from 5-fluorouracil and 5-fluorouridine is compartmentalized. , 1984, Biochemical and biophysical research communications.
[8] Y. Cheng,et al. Human thymidylate synthetase. II. Derivatives of pteroylmono- and -polyglutamates as substrates and inhibitors. , 1978, The Journal of biological chemistry.
[9] I. I. Kaiser,et al. Identification of 5‐flourocytidine in RNA from Escherichia coli grown in the presence of 5‐fluorouracil , 1973, FEBS letters.
[10] F Valeriote,et al. 5-Fluorouracil (FUra). , 1984, Pharmacology & therapeutics.
[11] B. Dolnick,et al. 5-Fluorouracil substitution alters pre-mRNA splicing in vitro. , 1988, The Journal of biological chemistry.
[12] D. Kufe,et al. 5-Fluorouracil incorporation in DNA of human breast carcinoma cells. , 1982, Cancer research.
[13] R. Glazer,et al. Synergistic effect of 5-fluorouracil and N-(phosphonacetyl)-L-aspartate on cell growth and ribonucleic acid synthesis in human mammary carcinoma. , 1981, Biochemical pharmacology.
[14] J. Grem,et al. Enhancement of 5-fluorouracil's anticancer activity by dipyridamole. , 1989, Pharmacology & therapeutics.
[15] B. Chabner,et al. Assay of 5-fluorodeoxyuridine 5'-monophosphate deoxyuridine 5'-monophosphate pools following 5-fluorouracil. , 1974, Cancer research.
[16] Y. Wataya,et al. Imbalance of deoxyribonucleoside triphosphates, DNA double-strand breaks, and cell death caused by 2-chlorodeoxyadenosine in mouse FM3A cells. , 1989, Cancer research.
[17] S. Spiegelman,et al. Potentiation of the anti‐tumor activity of 5FU by thymidine and its correlation with the formation of (5FU) RNA , 1980, Cancer.
[18] F. M. Huennekens,et al. Overview: rational basis for development of fluoropyrimidine/5-formyltetrahydrofolate combination chemotherapy. , 1988, Advances in experimental medicine and biology.
[19] P. Sharp,et al. Splicing of messenger RNA precursors. , 1985, Harvey lectures.
[20] H. Ingraham,et al. 2'-deoxyribosyl analogues of UDP-N-acetylglucosamine in cells treated with methotrexate or 5-fluorodeoxyuridine. , 1983, The Journal of biological chemistry.
[21] R. Howell,et al. Turnover of Ribosomal RNA in Rat Liver , 1965, Science.
[22] P. Houghton,et al. Biochemical determinants of responsiveness to 5-fluorouracil and its derivatives in xenografts of human colorectal adenocarcinomas in mice. , 1981, Cancer research.
[23] R. Diasio,et al. The effect of 5-fluorouracil on DNA chain elongation in intact bone marrow cells. , 1985, Biochemical and biophysical research communications.
[24] H. G. Mandel,et al. Effects of 5-fluorouracil on 5-fluorodeoxyuridine 5'-monophosphate and 2-deoxyuridine 5'-monophosphate pools, and DNA synthesis in solid mouse L1210 and rat Walker 256 tumors. , 1978, Cancer research.
[25] P. Danenberg,et al. Fluorinated pyrimidines as tight-binding inhibitors of thymidylate synthetase. , 1981, Pharmacology & therapeutics.
[26] R. I. Glazer,et al. Association of cell lethality with incorporation of 5-fluorouracil and 5-fluorouridine into nuclear RNA in human colon carcinoma cells in culture. , 1982, Molecular pharmacology.
[27] P. Houghton,et al. Characterization of the pools of 5,10-methylenetetrahydrofolates and tetrahydrofolates in xenografts of human colon adenocarcinoma. , 1988, Cancer research.
[28] R. Diasio,et al. Formation of conjugates of 2-fluoro-beta-alanine and bile acids during the metabolism of 5-fluorouracil and 5-fluoro-2-deoxyuridine in the isolated perfused rat liver. , 1988, Cancer research.
[29] F. Berger,et al. A naturally occurring variation in thymidylate synthase structure is associated with a reduced response to 5-fluoro-2'-deoxyuridine in a human colon tumor cell line. , 1988, Molecular pharmacology.
[30] D. Kufe,et al. Enhancement of 5-fluorouracil incorporation into human lymphoblast ribonucleic acid. , 1981, Biochemical pharmacology.
[31] H. Krokan,et al. Uracil DNa-glycosylase from HeLa cells: general properties, substrate specificity and effect of uracil analogs. , 1981, Nucleic acids research.
[32] C. Heidelberger,et al. Fluorinated Pyrimidines, A New Class of Tumour-Inhibitory Compounds , 1957, Nature.
[33] U. Lönn,et al. Interaction between 5-fluorouracil and DNA of human colon adenocarcinoma. , 1984, Cancer research.
[34] R. Diasio,et al. Relationship between dihydropyrimidine dehydrogenase activity and plasma 5-fluorouracil levels with evidence for circadian variation of enzyme activity and plasma drug levels in cancer patients receiving 5-fluorouracil by protracted continuous infusion. , 1990, Cancer research.
[35] B. Magasanik,et al. THE ROLES OF INDUCER AND CATABOLITE REPRESSOR IN THE SYNTHESIS OF BETA-GALACTOSIDASE BY ESCHERICHIA COLI. , 1964, Journal of molecular biology.
[36] D. Santi,et al. Cytotoxicity of 5-fluoro-2'-deoxyuridine: requirement for reduced folate cofactors and antagonism by methotrexate. , 1978, Proceedings of the National Academy of Sciences of the United States of America.
[37] B. Leyland-Jones,et al. Role of thymidine in biochemical modulation: a review. , 1987, Cancer research.
[38] D. Shugar,et al. Infrared and ultraviolet studies on the tautomeric equilibria in aqueous medium between monoanionic species of uracil, thymine, 5-fluorouracil, and other 2,4-diketopyrimidines. , 1965, Journal of the American Chemical Society.
[39] E. Cadman,et al. Acute effect of 5-fluorouracil on cytoplasmic and nuclear dihydrofolate reductase messenger RNA metabolism. , 1986, The Journal of biological chemistry.
[40] P. Danenberg,et al. Deoxyuridylate effects on thymidylate synthase-5-fluorodeoxyuridylate-folate ternary complex formation. , 1989, Biochemical pharmacology.
[41] P. Houghton,et al. Effect of polyglutamylation of 5,10-methylenetetrahydrofolate on the binding of 5-fluoro-2'-deoxyuridylate to thymidylate synthase purified from a human colon adenocarcinoma xenograft. , 1989, Biochemical pharmacology.
[42] Y. Cheng,et al. Effects of 5-fluoro-2'-deoxyuridine on DNA metabolism in HeLa cells. , 1983, Molecular pharmacology.
[43] R. Diasio,et al. Metabolism of 5-fluorouracil to an N-cholyl-2-fluoro-beta-alanine conjugate: previously unrecognized role for bile acids in drug conjugation. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[44] S. Greer,et al. Tumor-selective metabolism of 5-fluoro-2'-deoxycytidine coadministered with tetrahydrouridine compared to 5-fluorouracil in mice bearing Lewis lung carcinoma. , 1987, Cancer research.
[45] C. Takimoto,et al. Precursor-dependent differences in the incorporation of fluorouracil in RNA. , 1986, Molecular pharmacology.
[46] P. Plagemann,et al. Nucleotide pools of Novikoff rat hepatoma cells growing in suspension culture. II. Independent snucleotide pools for nucleic acid synthesis , 1971 .
[47] B. Leyland-Jones,et al. Enhancement of the antitumor activity of 5-fluorouracil by uridine rescue. , 1989, Pharmacology & therapeutics.
[48] J. Pink,et al. Effects of 5-fluorouracil on dihydrofolate reductase and dihydrofolate reductase mRNA from methotrexate-resistant KB cells. , 1985, The Journal of biological chemistry.
[49] D. Santi,et al. Methods for the complete analysis of 5-fluorouracil metabolites in cell extracts. , 1981, Analytical biochemistry.
[50] H. Pitot,et al. Inhibition of ribosomal ribonucleic acid maturation in Novikoff hepatoma cells by 5-fluorouracil and 5-fluorouridine. , 1973, The Journal of biological chemistry.
[51] D. Balinsky,et al. Activities of some enzymes of pyrimidine and DNA synthesis in a rat transplantable hepatoma and human primary hepatomas, in cell lines derived from these tissues, and in human fetal liver. , 1980, Cancer research.
[52] H. Mandel. The Incorporation of 5-Fluorouracil Into RNA and its Molecular Consequences , 1969 .
[53] R. Diasio,et al. Circadian variation of 5-fluorouracil catabolism in isolated perfused rat liver. , 1989, Cancer research.
[54] I. Eto,et al. Determination of three different pools of reduced one-carbon-substituted folates. II. Quantitation and chain-length determination of the pteroylpolyglutamates of rat liver. , 1981, Analytical biochemistry.
[55] W. Parker,et al. Dissociation of 5-fluorouracil-induced DNA fragmentation from either its incorporation into DNA or its cytotoxicity in murine T-lymphoma (S-49) cells. , 1987, Cancer research.
[56] B. Ardalan,et al. An update on the biochemistry of 5-fluorouracil. , 1981, Cancer treatment reviews.
[57] C. Takimoto,et al. Fluoropyrimidine-mediated changes in small nuclear RNA. , 1986, Journal of Biological Chemistry.
[58] Z. Wang,et al. Uracil-DNA glycosylase inhibitor gene of bacteriophage PBS2 encodes a binding protein specific for uracil-DNA glycosylase. , 1989, The Journal of biological chemistry.
[59] E. Friedberg,et al. Inhibitor of uracil-DNA glycosylase induced by bacteriophage PBS2. Purification and preliminary characterization. , 1980, The Journal of biological chemistry.
[60] B. Shane,et al. Regulation of folylpoly-gamma-glutamate synthesis in mammalian cells. In vivo and in vitro synthesis of pteroylpoly-gamma-glutamates by Chinese hamster ovary cells. , 1982, The Journal of biological chemistry.
[61] T. Lindahl. DNA repair enzymes. , 1982, Annual review of biochemistry.
[62] U. Lönn,et al. The increased cytotoxicity in colon adenocarcinoma of methotrexate-5-fluorouracil is not associated with increased induction of lesions in DNA by 5-fluorouracil. , 1986, Biochemical pharmacology.
[63] T. Watanabe,et al. Effects of 5-fluorouracil on globin mRNA synthesis in murine erythroleukemia cells. , 1986, Biochemistry.
[64] S. Greer,et al. Metabolic channeling of 5-fluoro-2'-deoxycytidine utilizing inhibitors of its deamination in cell culture. , 1985, Molecular pharmacology.
[65] Y. Wataya,et al. Deoxyribonucleoside triphosphate imbalance. 5-Fluorodeoxyuridine-induced DNA double strand breaks in mouse FM3A cells and the mechanism of cell death. , 1987, The Journal of biological chemistry.
[66] K. Danenberg,et al. Effect of 5, 10-methylenetetrahydrofolate on the dissociation of 5-fluoro-2'-deoxyuridylate from thymidylate synthetase: evidence for an ordered mechanism. , 1978, Biochemistry.
[67] P. Arenaz,et al. Purification and properties of the human placental uracil DNA glycosylase. , 1987, Biochimica et biophysica acta.
[68] R. I. Glazer,et al. Analysis of the effect of 5-fluorouracil on the synthesis and translation of polysomal poly(A)RNA from Ehrlich ascites cells. , 1981, Molecular pharmacology.
[69] Peter Murray-Rust,et al. Intermolecular interactions of the carbon-fluorine bond: the crystallographic environment of fluorinated carboxylic acids and related structures , 1983 .
[70] C. Will,et al. 5-Fluorouracil inhibits dihydrofolate reductase precursor mRNA processing and/or nuclear mRNA stability in methotrexate-resistant KB cells. , 1989, The Journal of biological chemistry.
[71] P. Danenberg. Thymidylate synthetase - a target enzyme in cancer chemotherapy. , 1977, Biochimica et biophysica acta.
[72] H. Fraenkel-conrat,et al. Biological consequences of incorporation of 5-fluorocytidine in the RNA of 5-fluorouracil-treated eukaryotic cells. , 1976, Proceedings of the National Academy of Sciences of the United States of America.
[73] B. Leyland-Jones,et al. Overview of current status and future direction of clinical trials with 5-fluorouracil in combination with folinic acid. , 1987, Cancer treatment reports.
[74] D. Kufe,et al. Incorporation of 5-fluorodeoxycytidine and metabolites into nucleic acids of human MCF-7 breast carcinoma cells. , 1986, Cancer research.
[75] H. Ingraham,et al. DNA fragmentation and cytotoxicity from increased cellular deoxyuridylate. , 1986, Biochemistry.
[76] C. Baugh,et al. The uptake of pteroyl(14-C)glutamic acid into rat liver and its incorporation into the natural pteroyl poly-gamma-glutamates of that organ. , 1974, Biochemistry.
[77] K. Danenberg,et al. Effect of 5-fluorouracil substitution on the self-splicing activity of Tetrahymena ribosomal RNA. , 1990, Cancer research.
[78] D. Kerr. 5-Fluorouracil and folinic acid: interesting biochemistry or effective treatment? , 1989, British Journal of Cancer.
[79] C. Heidelberger,et al. Biochemical determinants of tumor sensitivity to 5-fluorouracil: ultrasensitive methods for the determination of 5-fluoro-2'-deoxyuridylate, 2'-deoxyuridylate, and thymidylate synthetase. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[80] H. Ingraham,et al. Nucleotide levels and incorporation of 5-fluorouracil and uracil into DNA of cells treated with 5-fluorodeoxyuridine. , 1982, Molecular pharmacology.
[81] S. Spiegelman,et al. Incorporation of 5-fluorouracil into murine bone marrow DNA in vivo. , 1984, Cancer research.
[82] R. Diasio,et al. Alteration of the secondary structure of newly synthesized DNA from murine bone marrow cells by 5-fluorouracil. , 1986, Cancer research.
[83] R. Donehower,et al. Biochemical interactions between N-(phosphonacetyl)-L-aspartate and 5-fluorouracil. , 1982, Molecular Pharmacology.
[84] C. Will,et al. 5-Fluorouracil augmentation of dihydrofolate reductase gene transcripts containing intervening sequences in methotrexate-resistant KB cells. , 1986, Molecular pharmacology.
[85] S. Yoshida,et al. Enhancement of the incorporation of 5-fluorodeoxyuridylate into DNA of HL-60 cells by metabolic modulations. , 1983, Cancer research.
[86] H. Ingraham,et al. Mechanism for exclusion of 5-fluorouracil from DNA. , 1980, Cancer research.
[87] B. Chabner,et al. Biochemical determinants of 5-fluorouracil response in vivo. The role of deoxyuridylate pool expansion. , 1975, The Journal of clinical investigation.
[88] D. Fernandes,et al. Dissociation of thymidylate biosynthesis from DNA biosynthesis by 5-fluoro-2'-deoxyuridine and 5,8-dideazaisofolic acid. , 1986, Cancer research.
[89] Masao Tanaka,et al. Utilization of 5-Fluoro-2′-deoxyuridine Triphosphate and 5-Fluoro-2′-deoxycytidine Triphosphate in DNA Synthesis by DNA Polymerases α and β from Calf Thymus , 1981 .
[90] Y. Cheng,et al. The role of deoxyuridine triphosphate nucleotidohydrolase, uracil-DNA glycosylase, and DNA polymerase alpha in the metabolism of FUdR in human tumor cells. , 1980, Molecular pharmacology.
[91] J. Laskin,et al. Assessment of growth-limiting events caused by 5-fluorouracil in mouse cells and in human cells. , 1980, Cancer research.
[92] C. Heidelberger,et al. The incorporation of 5-fluoro-2'-deoxyuridine into DNA of mammalian tumor cells. , 1981, Biochemical and biophysical research communications.
[93] J. Pink,et al. 5-fluorouracil modulation of dihydrofolate reductase RNA levels in methotrexate-resistant KB cells. , 1983, The Journal of biological chemistry.
[94] J. Scott,et al. The identification of the forms of folate found in the liver, kidney and intestine of the monkey and their biosynthesis from exogenous pteroylglutamate (folic acid). , 1974, Biochimica et biophysica acta.
[95] R. Moran. Leucovorin enhancement of the effects of the fluoropyrimidines on thymidylate synthase , 1989 .
[96] S. Greer,et al. Use of 5-fluorodeoxycytidine and tetrahydrouridine to exploit high levels of deoxycytidylate deaminase in tumors to achieve DNA- and target-directed therapies. , 1984, Cancer research.
[97] Z. Dominski,et al. Inhibition of pre-mRNA splicing by 5-fluoro-, 5-chloro-, and 5-bromouridine. , 1989, The Journal of biological chemistry.
[98] J. Laskin,et al. Effect of excess folates and deoxyinosine on the activity and site of action of 5-fluorouracil. , 1981, Cancer research.
[99] Y. Maehara,et al. Activities of various enzymes of pyrimidine nucleotide and DNA syntheses in normal and neoplastic human tissues. , 1982, Gan.
[100] J. Bertino,et al. Enhancement of the antitumor effects of 5-fluorouracil by folinic acid. , 1990, Pharmacology & therapeutics.
[101] P. Goldman. The carbon-fluorine bond in compounds of biological interest. , 1969, Science.
[102] R. Diasio,et al. Dihydrofluorouracil, a fluorouracil catabolite with antitumor activity in murine and human cells. , 1985, Cancer research.
[103] M. Kane,et al. Effect of intracellular folate concentration on the modulation of 5-fluorouracil cytotoxicity by the elevation of phosphoribosylpyrophosphate in cultured human KB cells. , 1987, Cancer research.
[104] C. Will,et al. 5-Fluorouracil augmentation of dihydrofolate reductase RNA containing contiguous exon and intron sequences in KB7B cells. , 1987, The Journal of biological chemistry.
[105] C. Takimoto,et al. Correlation between ribosomal RNA production and RNA-directed fluoropyrimidine cytotoxicity. , 1987, Biochemical pharmacology.
[106] P. Barr,et al. On the mechanism of inhibition of DNA-cytosine methyltransferases by cytosine analogs , 1983, Cell.
[107] A. Calvert,et al. Increased thymidylate synthase in L1210 cells possessing acquired resistance to N10-propargyl-5,8-dideazafolic acid (CB3717): development, characterization, and cross-resistance studies. , 1986, Cancer research.
[108] C. Myers. The pharmacology of the fluoropyrimidines. , 1981, Pharmacological reviews.
[109] R. Diasio,et al. Modulation of 5-fluorouracil catabolism in isolated rat hepatocytes with enhancement of 5-fluorouracil glucuronide formation. , 1985, Cancer research.
[110] D. Kufe,et al. 5-Fluoro-2'-deoxyuridine incorporation in L1210 DNA. , 1981, The Journal of biological chemistry.
[111] K. Keyomarsi,et al. Folinic acid augmentation of the effects of fluoropyrimidines on murine and human leukemic cells. , 1986, Cancer research.
[112] Y. Cheng,et al. Uracil DNA-glycosylase. Purification and properties of this enzyme isolated from blast cells of acute myelocytic leukemia patients. , 1980, The Journal of biological chemistry.
[113] L. Loeb,et al. Endogenous carcinogenesis: molecular oncology into the twenty-first century--presidential address. , 1989, Cancer research.
[114] C. Benz,et al. The influence of methotrexate pretreatment on 5-fluorouracil metabolism in L1210 cells. , 1981, The Journal of biological chemistry.
[115] J R Bertino,et al. 5-fluorouracil-methotrexate synergy: enhancement of 5-fluorodeoxyridylate binding to thymidylate synthase by dihydropteroylpolyglutamates. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[116] K. Keyomarsi,et al. Mechanism of the cytotoxic synergism of fluoropyrimidines and folinic acid in mouse leukemic cells. , 1988, The Journal of biological chemistry.
[117] E. Frei,et al. Selective expansion of 5,10-methylenetetrahydrofolate pools and modulation of 5-fluorouracil antitumor activity by leucovorin in vivo. , 1989, Cancer research.
[118] J. Armand,et al. 19F NMR spectrometry evidence for bile acid conjugates of alpha-fluoro-beta-alanine as the main biliary metabolites of antineoplastic fluoropyrimidines in humans. , 1988, Drug metabolism and disposition: the biological fate of chemicals.
[119] D. Kufe,et al. Lethality associated with incorporation of 5-fluorouracil into preribosomal RNA. , 1984, Molecular pharmacology.